A Community-based Depression Screening Intervention for Middle-aged Suicide
NCT ID: NCT02468466
Last Updated: 2015-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89700 participants
INTERVENTIONAL
2005-01-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Story-Centred Care Intervention Program in Older Persons Living in Long-term Care Facilities
NCT02965937
Prevention of Suicide in the Elderly
NCT00000367
A Study on Improving Detection and Management of Suicide Risk Among Depressed Patients in Primary Care
NCT00386711
Ask Suicide-Screening Questions to Everyone in Medical Settings (asQ em): Development of a Suicide Risk Screening Instrument for Adult Medical Inpatients
NCT02140177
The Meaning of Suicidality for Older Persons With Suicidal Tendencies and Their Families
NCT01729377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multi-level suicide prevention programs
The study team, including staff members from the intervention municipalities, provided each municipality with a standardized form of the work plan used in our study. The intervention municipality autonomously conducted the intervention program during the implementation period.
Multi-level suicide prevention programs
The intervention included both screening and educational components. The screening component invited residents aged 36-64 years to participate in a two-step screening program. In the initial screening, a self-report questionnaire were mailed to all of those residents in the priority districts with a past high suicide rate. The second stage was conducted for the participants who screened positive though a semi-structural interview. Based on the results, participants who were diagnosed with a major depressive episode were provided with a referral to a psychiatry and support for treatment adherence. Written feedback on the screening results was mailed to all respondents. The educational component was implemented through workshops open to the general public (3 times every year) and local public newsletters (twice every year) designed to improve access and adherence to treatment and to reduce stigma associated with suicide and depression.
Community intervention as usual
Suicide prevention program as usual
Suicide prevention program as usual
Usual mental health program (not including depression screening among middle-aged)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multi-level suicide prevention programs
The intervention included both screening and educational components. The screening component invited residents aged 36-64 years to participate in a two-step screening program. In the initial screening, a self-report questionnaire were mailed to all of those residents in the priority districts with a past high suicide rate. The second stage was conducted for the participants who screened positive though a semi-structural interview. Based on the results, participants who were diagnosed with a major depressive episode were provided with a referral to a psychiatry and support for treatment adherence. Written feedback on the screening results was mailed to all respondents. The educational component was implemented through workshops open to the general public (3 times every year) and local public newsletters (twice every year) designed to improve access and adherence to treatment and to reduce stigma associated with suicide and depression.
Suicide prevention program as usual
Usual mental health program (not including depression screening among middle-aged)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A municipal area with the higher suicide rate than the prefectural average.
* A municipal area having the sufficient and coverable size to serve the intervention (population 10,000-99,999).
Exclusion Criteria
36 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aomori University of Health and Welfare
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hirofumi Oyama
Faculty of Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hirofumi Oyama, MD, PhD
Role: STUDY_DIRECTOR
Aomori University of Health and Welfare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Control group
Fujisaki, Aomori, Japan
Intervention group
Gonohe, Aomori, Japan
Intervention group
Hashikami, Aomori, Japan
Intervention group
Hirakawa, Aomori, Japan
Control group
Hiranai, Aomori, Japan
Intervention group
Nanaku, Aomori, Japan
Intervention group
Oirase, Aomori, Japan
Control group
ĹŚwani, Aomori, Japan
Control group
Rokunohe, Aomori, Japan
Control group
Tohoku, Aomori, Japan
Control group
Towada, Aomori, Japan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Oyama H, Sakashita T. Effects of universal screening for depression among middle-aged adults in a community with a high suicide rate. J Nerv Ment Dis. 2014 Apr;202(4):280-6. doi: 10.1097/NMD.0000000000000119.
Oyama H, Sakashita T. Differences in specific depressive symptoms among community-dwelling middle-aged Japanese adults before and after a universal screening intervention. Soc Psychiatry Psychiatr Epidemiol. 2014 Feb;49(2):251-8. doi: 10.1007/s00127-013-0735-6. Epub 2013 Jul 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KAKENHI #70404829
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.